Announcing the 2023-2024 Frank J. and Eleanor Maslowski Charitable Trust CHIP-CTO Fellow at the MHIF Center for Coronary Artery Disease

Complex High Risk Indicated Percutaneous Coronary Interventions (CHIP) - Chronic Total Occlusion (CTO) Fellowship
Aug 16, 2023
Image
Ahmed Al-Ogaili

The Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation® (MHIF) is dedicated to improving clinical practice and ultimately discovering lifesaving treatments through innovative cardiovascular research. As part of the educational aim for the center, a one-year fellowship was created to provide a robust experience to an individual interested in training in complex percutaneous coronary interventions and interventional cardiology research.

MHIF is delighted to welcome Ahmed Al-Ogaili, MD, as the Frank J. and Eleanor Maslowski Charitable Trust CHIP-CTO Fellow as of July 1, 2023.

Dr. Al-Ogaili joins us from Rush University Medical Center, Chicago, where he completed his training in interventional cardiology. He obtained his medical degree from Jordan University of Science and Technology in Jordan. Subsequently, Dr. Al-Ogaili moved to the United States and completed his Internal Medicine residency and Cardiovascular Disease fellowship at Cook County Hospital in Chicago. During his training he served as a Chief medical resident and Chief cardiology fellow and won multiple clinical excellence awards.

Throughout his medical training, Dr. Al-Ogaili has been actively involved in research, with presentations at the major cardiology congresses and peer-reviewed publications. He is Board Certified in Internal Medicine, Nuclear Cardiology, Echocardiography, Cardiac CT, and cardiovascular diseases.

The Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation is dedicated to improving clinical practice and ultimately discovering life-saving treatments through innovative cardiovascular research. The Frank J. and Eleanor Maslowski Charitable Trust CHIP-CTO Fellowship Program is a 1-year hybrid clinical and research training program for Interventional Cardiologists focused on specialized training in complex and high-risk percutaneous coronary interventions, including patient selection, procedural planning, use of advanced interventional techniques, and prevention and management of complications. The program also includes a clinical research focus on complex percutaneous coronary interventions and coronary artery disease.

The curriculum for the program consists of:

  • Chronic total occlusion (CTO) interventions
  • Advanced intravascular imaging and physiology
  • Bifurcations, thrombus management, treatment of acute coronary syndromes
  • Calcification and tortuosity
  • Hemodynamic support and treatment of cardiogenic shock
  • Complication prevention and management, radiation safety
  • Research in complex percutaneous coronary interventions and coronary artery disease

MHIF is strongly positioned for success with the Center for Coronary Artery Disease through its partnership with 70+ Minneapolis Heart Institute® cardiologists, who see more than 50,000 individual patients at more than 60,000 clinic visits each year at Abbott Northwestern and United Hospitals.

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.